Emilia Alors-Pérez, Sergio Pedraza-Arevalo, Ricardo Blázquez-Encinas, Víctor García-Vioque, Antonio Agraz-Doblas, Elena M. Yubero-Serrano, . . . Justo P. Castaño. (2024). Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response. Elsevier.
Chicago Style (17th ed.) CitationEmilia Alors-Pérez, et al. Altered CELF4 Splicing Factor Enhances Pancreatic Neuroendocrine Tumors Aggressiveness Influencing MTOR and Everolimus Response. Elsevier, 2024.
MLA (9th ed.) CitationEmilia Alors-Pérez, et al. Altered CELF4 Splicing Factor Enhances Pancreatic Neuroendocrine Tumors Aggressiveness Influencing MTOR and Everolimus Response. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.